Mar-95 -

Gynecological Group

EORTC 55865 – Phase III study for the treatment of ovarian cancer FIGO stages IIB and C, III and IV.

EORTC found that in patients with advanced epithelial ovarian cancer, debulking surgery after chemotherapy, lengthened progression free and overall survival, and reduced risk of death by one third in these patients.


Go to Top